A/Prof Laurence Albiges and Dr Monty Pal discuss the changing landscape and biomarkers in metastatic renal cell carcinoma with A/Prof Andrew Weickhardt.
Assistant Prof Angie Smith discusses the four types of BCG failure and subsequent management in patients with non-muscle invasive bladder cancer.
Dr Tombal explores the future of academic urology. How can we get surgeons back into research?
Prof Chris Sweeney discusses intermittent versus continuous ADT in metastatic hormone sensitive prostate cancer. Can you balance survival and quality of life?
Dr George Hruby dares to ask if you can radiate the prostate more than once.
Dr Haryana Dhillon: Are we doing enough to address anxiety and depression in patients with prostate cancer and what can we do about it?
Dr Joseph Ischia chats with ANZUP 2018 Convenor Henry Woo. Enjoy the highlights of the conference through the eyes of the convenor.
As ANZUP celebrates its 10th Anniversary, Prof Ian Davis reflects on how ANZUP brings people together to improve patient outcomes.
Dr Carmel Pezaro talks with Dr Ben Tran about ‘Bringing Data Back’. He’s sexy. He’s funny. You’ll love him.
Dr Niazi discusses prostate oligometastatic targeted therapy in castration resistant prostate cancer.
Dr Joseph Ischia chats with David Pryor, the convenor of the 2019 ANZUP conference in Brisbane July 21-23.
Lisa Horvath discusses her research on how a man's plasma lipid signature can predict prognosis in castration resistant prostate cancer
Peter Black discusses the potential new molecular classification of bladder cancers.
Lisa Butler discusses her research on identifying drug response biomarkers in prostate cancer
Homi Zargar discusses some of the controversies in kidney cancer management.
Craig Gedye discusses new biomarkers for kidney cancer.
Alex Kutikov discusses his new metric for determining the utility of MRI-US fusion prostate biopsy.
Prue Cormie discusses the multitude of benefits of exercise in men with prostate cancer.
Camille Short discusses her innovative website to support men underoging treatment for metastatic prostate cancer
Silke Gillessen discusses the interesting findings from the Advanced Prostate Cancer Consensus Conference in St Gallen.
Michael Hofman discusses the new ANZUP/PCFA trial investigating therapeutic Lutetium (Lu-177) PSMA for men with advanced mCRPC.
Bente Thoft Jensen discusses the advancements in prehabiliatation prior to radical cystectomy.
Dennis Taaffe discusses the RADAR trial investigating the important benefits of exercise in men with prostate cancer
David Quinn discusses the KEYNOTE-045 trial on the benefits of pembrolizumab in second line treatment of advanced bladder cancer
Peter Black discusses the dizzying array of new treamtment options on the horizon for advanced bladder cancer
Renea Taylor discusses her research on the poor prognosis associated with BRCA 2 mutation prostate cancer
Alex Kutikov discusses predictors of pT0 bladder cancer after neoadjuvant chemotherapy; can we avoid cystectomy in these patients?
Matthew Roberts discusses the role of seminal plasma (ejaculate) for monitoring men on active surveillance for prostate cancer
Ada Cheung discusses the often missed diagnosis of hypogonadism in men who have had treatment for testicular cancer.
Bill Catalona gave the annual Patrick C Walsh lecture and discusses the 3 big wins in improving prostate cancer outcomes in the PSA era.
